CELGENE CORP /DE/ 4
4 · CELGENE CORP /DE/ · Filed Dec 24, 2013
Insider Transaction Report
Form 4
STEIN LAWRENCE V
See Remarks
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2013-12-23−12,062→ 41,271 totalExercise: $78.66Exp: 2022-12-03→ Common Stock (12,062 underlying) - Exercise/Conversion
Common Stock
2013-12-23$78.66/sh+12,062$948,797→ 12,112 total - Sale
Common Stock
2013-12-23$168.19/sh−12,062$2,028,685→ 50 total
Holdings
- 55(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $168.10 to $168.43, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to this Form 4.
- [F2]The option was fully exercisable.
- [F3]The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).